Movement Disorders

Citations 111-120 of 455 total displayed.

Past content (since Jan 1998):

Original Contributions
Screen for Excess FMR1 Premutation Alleles Among Males With Parkinsonism

Jeremy Kraff; Hiu-Tung Tang; Roberto Cilia; Margherita Canesi; Gianni Pezzoli; Stefano Goldwurm; Paul J. Hagerman; Flora Tassone
Arch Neurol 2007; 64: 1002-1006. [Abstract] [Full text] [PDF]  

Research Letters
Glucocerebrosidase Mutations and Risk of Parkinson Disease in Chinese Patients

Eng-King Tan; Justina Tong; Stephanie Fook-Chong; Yuen Yih; Meng-Cheong Wong; Ratnagopal Pavanni; Yi Zhao
Arch Neurol 2007; 64: 1056-1058. [Extract] [Full text] [PDF]  

Editorials
Juvenile-Onset Huntington Disease: A Matter of Perspective

Kevin Biglan; Ira Shoulson
Arch Neurol 2007; 64: 783-784. [Extract] [Full text] [PDF]  

Original Contributions
Psychiatric and Cognitive Difficulties as Indicators of Juvenile Huntington Disease Onset in 29 Patients

Pascale Ribaï; Karine Nguyen; Valérie Hahn-Barma; Isabelle Gourfinkel-An; Marie Vidailhet; Antoine Legout; Catherine Dodé; Alexis Brice; Alexandra Dürr
Arch Neurol 2007; 64: 813-819. [Abstract] [Full text] [PDF]  

Original Contributions
Risk Factors for the Development of Pedal Edema in Patients Using Pramipexole

Galit Kleiner-Fisman; David N. Fisman
Arch Neurol 2007; 64: 820-824. [Abstract] [Full text] [PDF]  

Original Contributions
Inflammatory Cytokine Gene Polymorphisms and Increased Risk of Parkinson Disease

Angelika D. Wahner; Janet S. Sinsheimer; Jeff. M. Bronstein; Beate Ritz
Arch Neurol 2007; 64: 836-840. [Abstract] [Full text] [PDF]  

Original Contributions
Daytime Hypoxemia, Sleep-Disordered Breathing, and Laryngopharyngeal Findings in Multiple System Atrophy

Takayoshi Shimohata; Hideo Shinoda; Hideaki Nakayama; Tetsutaro Ozawa; Kenshi Terajima; Hirohisa Yoshizawa; Yoko Matsuzawa; Osamu Onodera; Satoshi Naruse; Keiko Tanaka; Sugata Takahashi; Fumitake Gejyo; Masatoyo Nishizawa
Arch Neurol 2007; 64: 856-861. [Abstract] [Full text] [PDF]  

Observations
Manganese-Induced Parkinsonism Associated With Methcathinone (Ephedrone) Abuse

Rob M. A. de Bie; Richard M. Gladstone; Antonio P. Strafella; Ji-Hyun Ko; Anthony E. Lang
Arch Neurol 2007; 64: 886-889. [Abstract] [Full text] [PDF]  

Clinical Trials
Randomized, Double-blind, Placebo-Controlled Trial on Symptomatic Effects of Coenzyme Q₁₀ in Parkinson Disease

Alexander Storch; Wolfgang H. Jost; Peter Vieregge; Jörg Spiegel; Wolfgang Greulich; Joachim Durner; Thomas Müller; Andreas Kupsch; Henning Henningsen; Wolfgang H. Oertel; Gerd Fuchs; Wilfried Kuhn; Petra Niklowitz; Rainer Koch; Birgit Herting; Heinz Reichmann; for the German Coenzyme Q₁₀ Study Group
Arch Neurol 64.7.nct60005. [Abstract] [Full text] []  

Original Contributions
Transdermal Rotigotine: Double-blind, Placebo-Controlled Trial in Parkinson Disease

Joseph Jankovic; Ray L. Watts; Wayne Martin; Babak Boroojerdi; for the SP 512 Rotigotine Transdermal System Clinical Study Group
Arch Neurol 2007; 64: 676-682. [Abstract] [Full text] [PDF] [ Notice of Redundant Publication ]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46